Clinical Trial Update: Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome [EARLY_Phase 1]

View source ↗

Summary

Clinical trial update on an early-phase 1 study of ixazomib citrate, lenalidomide, and dexamethasone for POEMS syndrome (plasmacytoma) that has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmacytoma
• Poems Syndrome

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Ixazomib citrate (Ixazomib)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Mayo Clinic | Conditions: Plasmacytoma, POEMS Syndrome | EARLY_Phase 1 | Status: COMPLETED